PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
Ccent/2022/32 - KKR / IVI-RMA
Acquired
IVI-RMA
Description
IVI-RMA is a company, based in Spain, active in the field of reproductive medicine, providing medically assisted procreation and auxiliary services worldwide. In Portugal, IVI-RMA operates through its subsidiary Instituto Valenciano de Infertilidade - Clínica de Reproduction Assistida, Lda., with clinics in Lisbon and Faro.
Acquiring
KKR & Co. Inc.
Description
KKR is a global investment company that offers alternatives for the management of assets and capital markets and insurance solutions, controlling companies operating in Portugal in different sectors of the economy, namely GeneraLife Clinics S.L.U., with medically assisted procreation clinics in Lisbon and Porto, under the Ginemed brand.
Sector
  • Health & Pharmaceutical
Activity (NACE)
  • Q86 - Human health activities
Applicable legislation
Art. 37(1)(b) and (c) (Law 19)
Notification thresholds
Combined and Turnover thresholds
Type of merger
Horizontal
Cooperation with sector regulators
  • ERS - Health Regulatory Entity
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description

The notified concentration consists of the acquisition of sole control over IVI-RMA by KKR.
Timeline
2022-09-27
The AdC issued a non-opposition decision to the merger 32/2022 - KKR / IVI-RMA.
2022-07-29
KKR notifies the acquisition of sole control over IVI-RMA.
Click here to see your activities